Par Pharmaceutical Companies, Inc. (NYSE:PRX)

CAPS Rating: 3 out of 5

The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.

Recs

0
Player Avatar gowvu84 (< 20) Submitted: 2/2/2011 6:14:36 PM : Outperform Start Price: $36.31 PRX Score: +11.17

Like their cash to debt ratio

Featured Broker Partners


Advertisement